VEGF in biological control
- PMID: 17979153
- DOI: 10.1002/jcb.21579
VEGF in biological control
Abstract
Vascular endothelial growth factor A (VEGF-A) belongs to a family of heparin binding growth factors that include VEGF-B, VEGF-C, VEGF-D, and placental-like growth factor (PLGF). First discovered for its ability to regulate vascular endothelial cell permeability, VEGF is a well-known angiogenic factor that is important for vascular development and maintenance in all mammalian organs. The development of molecular tools and pharmacological agents to selectively inhibit VEGF function and block angiogenesis and/or vascular permeability has led to great promise in the treatment of various cancers, macular degeneration, and wound healing. However, VEGF is also important in animals for the regulation of angiogenesis, stem cell and monocyte/macrophage recruitment, maintenance of kidney and lung barrier functions and neuroprotection. In addition to its role in regulating endothelial cell proliferation, migration, and cell survival, VEGF receptors are also located on many non-endothelial cells and act through autrocrine pathways to regulate cell survival and function. The following review will discuss the role of VEGF in physiological angiogenesis as well as its role in non-angiogenic processes that take place in adult organs.
Copyright (c) 2007 Wiley-Liss, Inc.
Similar articles
-
Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.J Clin Oncol. 2005 Feb 10;23(5):1011-27. doi: 10.1200/JCO.2005.06.081. Epub 2004 Dec 7. J Clin Oncol. 2005. PMID: 15585754 Review.
-
Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.Integr Cancer Ther. 2005 Dec;4(4):315-21. doi: 10.1177/1534735405282557. Integr Cancer Ther. 2005. PMID: 16282508 Review.
-
Vascular endothelial growth factor.Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):789-91. doi: 10.1161/ATVBAHA.108.179663. Epub 2009 Jan 22. Arterioscler Thromb Vasc Biol. 2009. PMID: 19164810 Review.
-
Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.FEBS J. 2009 Sep;276(17):4636-43. doi: 10.1111/j.1742-4658.2009.07175.x. Epub 2009 Jul 31. FEBS J. 2009. PMID: 19664071 Review.
-
The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions.Clin Sci (Lond). 2005 Sep;109(3):227-41. doi: 10.1042/CS20040370. Clin Sci (Lond). 2005. PMID: 16104843 Review.
Cited by
-
The Influence of Different Irradiation Regimens on Inflammation and Vascularization in a Random-Pattern Flap Model.J Pers Med. 2023 Oct 21;13(10):1514. doi: 10.3390/jpm13101514. J Pers Med. 2023. PMID: 37888125 Free PMC article.
-
The changes of tumour vascular endothelial growth factor expression after neoadjuvant chemoradiation in patients with rectal adenocarcinoma.Contemp Oncol (Pozn). 2017;21(1):48-53. doi: 10.5114/wo.2017.66656. Epub 2017 Mar 22. Contemp Oncol (Pozn). 2017. PMID: 28435398 Free PMC article.
-
Skeletal myofiber VEGF deficiency leads to mitochondrial, structural, and contractile alterations in mouse diaphragm.J Appl Physiol (1985). 2019 Nov 1;127(5):1360-1369. doi: 10.1152/japplphysiol.00779.2018. Epub 2019 Sep 5. J Appl Physiol (1985). 2019. PMID: 31487223 Free PMC article.
-
KSHV-Mediated Angiogenesis in Tumor Progression.Viruses. 2016 Jul 20;8(7):198. doi: 10.3390/v8070198. Viruses. 2016. PMID: 27447661 Free PMC article. Review.
-
The Stimulation of Macrophages by Systematical Administration of GM-CSF Can Accelerate Adult Wound Healing Process.Int J Mol Sci. 2022 Sep 25;23(19):11287. doi: 10.3390/ijms231911287. Int J Mol Sci. 2022. PMID: 36232590 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources